These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24703465)

  • 21. Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway.
    Ji N; Yu JW; Ni XC; Wu JG; Wang SL; Jiang BJ
    Tumour Biol; 2016 Nov; 37(11):14637-14651. PubMed ID: 27619680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy.
    Tsurutani J; West KA; Sayyah J; Gills JJ; Dennis PA
    Cancer Res; 2005 Sep; 65(18):8423-32. PubMed ID: 16166321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EPHA2 blockade reverses acquired resistance to afatinib induced by EPHA2-mediated MAPK pathway activation in gastric cancer cells and avatar mice.
    Chen Z; Liu Z; Zhang M; Huang W; Li Z; Wang S; Zhang C; Dong B; Gao J; Shen L
    Int J Cancer; 2019 Nov; 145(9):2440-2449. PubMed ID: 30957241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FAK association with multiple signal proteins mediates pressure-induced colon cancer cell adhesion via a Src-dependent PI3K/Akt pathway.
    Thamilselvan V; Craig DH; Basson MD
    FASEB J; 2007 Jun; 21(8):1730-41. PubMed ID: 17317726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the PI3K/Akt pathway increases the chemosensitivity of gastric cancer to vincristine.
    Xie X; Tang B; Zhou J; Gao Q; Zhang P
    Oncol Rep; 2013 Aug; 30(2):773-82. PubMed ID: 23743572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.
    Kang MH; Kim JS; Seo JE; Oh SC; Yoo YA
    Exp Cell Res; 2010 Jan; 316(1):24-37. PubMed ID: 19835871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ORAI2 Promotes Gastric Cancer Tumorigenicity and Metastasis through PI3K/Akt Signaling and MAPK-Dependent Focal Adhesion Disassembly.
    Wu S; Chen M; Huang J; Zhang F; Lv Z; Jia Y; Cui YZ; Sun LZ; Wang Y; Tang Y; Verhoeft KR; Li Y; Qin Y; Lin X; Guan XY; Lam KO
    Cancer Res; 2021 Feb; 81(4):986-1000. PubMed ID: 33310726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways.
    Acosta JJ; Muñoz RM; González L; Subtil-Rodríguez A; Dominguez-Caceres MA; García-Martínez JM; Calcabrini A; Lazaro-Trueba I; Martín-Pérez J
    Mol Endocrinol; 2003 Nov; 17(11):2268-82. PubMed ID: 12907754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibronectin promotes migration and invasion of ovarian cancer cells through up-regulation of FAK-PI3K/Akt pathway.
    Yousif NG
    Cell Biol Int; 2014 Jan; 38(1):85-91. PubMed ID: 24115647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lewis y enhances CAM-DR in ovarian cancer cells by activating the FAK signaling pathway and upregulating Bcl-2/Bcl-XL expression.
    Yan L; Wang C; Lin B; Liu J; Liu D; Hou R; Wang Y; Gao L; Zhang S; Iwamori M
    Biochimie; 2015 Jun; 113():17-25. PubMed ID: 25726913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The MAPK pathway is a predominant regulator of HLA-A expression in esophageal and gastric cancer.
    Mimura K; Shiraishi K; Mueller A; Izawa S; Kua LF; So J; Yong WP; Fujii H; Seliger B; Kiessling R; Kono K
    J Immunol; 2013 Dec; 191(12):6261-72. PubMed ID: 24244023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of new small molecules inhibiting 67 kDa laminin receptor interaction with laminin and cancer cell invasion.
    Pesapane A; Di Giovanni C; Rossi FW; Alfano D; Formisano L; Ragno P; Selleri C; Montuori N; Lavecchia A
    Oncotarget; 2015 Jul; 6(20):18116-33. PubMed ID: 26062445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of CEACAM19 suppresses human gastric cancer through inhibition of PI3K/Akt and NF-κB.
    Zhao H; Xu J; Wang Y; Jiang R; Li X; Zhang L; Che Y
    Surg Oncol; 2018 Sep; 27(3):495-502. PubMed ID: 30217308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
    Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
    Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CXCL1 from tumor-associated lymphatic endothelial cells drives gastric cancer cell into lymphatic system via activating integrin β1/FAK/AKT signaling.
    Wang Z; Wang Z; Li G; Wu H; Sun K; Chen J; Feng Y; Chen C; Cai S; Xu J; He Y
    Cancer Lett; 2017 Jan; 385():28-38. PubMed ID: 27832972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of human 67-kDa laminin receptor sensitizes multidrug resistance colon cancer cell line SW480 for apoptosis induction.
    Lu CL; Xu J; Yao HJ; Luo KL; Li JM; Wu T; Wu GZ
    Tumour Biol; 2016 Jan; 37(1):1319-25. PubMed ID: 26293895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling.
    Luo J; Yao JF; Deng XF; Zheng XD; Jia M; Wang YQ; Huang Y; Zhu JH
    J Exp Clin Cancer Res; 2018 Feb; 37(1):23. PubMed ID: 29426357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adhesion to fibronectin regulates Hippo signaling via the FAK-Src-PI3K pathway.
    Kim NG; Gumbiner BM
    J Cell Biol; 2015 Aug; 210(3):503-15. PubMed ID: 26216901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual PI3K/mTOR inhibitor BEZ235 as a promising therapeutic strategy against paclitaxel-resistant gastric cancer via targeting PI3K/Akt/mTOR pathway.
    Chen D; Lin X; Zhang C; Liu Z; Chen Z; Li Z; Wang J; Li B; Hu Y; Dong B; Shen L; Ji J; Gao J; Zhang X
    Cell Death Dis; 2018 Jan; 9(2):123. PubMed ID: 29374144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells.
    Jin YP; Fishbein MC; Said JW; Jindra PT; Rajalingam R; Rozengurt E; Reed EF
    Hum Immunol; 2004 Apr; 65(4):291-302. PubMed ID: 15120184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.